Mangalam Organics Limited
4,029words
0turns
0analyst exchanges
0executives
Key numbers — 30 extracted
rs,
276140 Date: May 13, 2025 BSE Limited Listing & Compliance Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai – 400001. Scrip: 514418 The National Stock Exchange of India Limited
10,000 MT
angalam Organics Ltd. got listed on NSE Successfully completed the expansion to manufacture 10,000 MT of Camphor 7 Our Business Segments B2B - Terpene Camphor: Religious use, healthcare products,
94%
2B Revenue break-up of Mangalam Organics Limited Business-to-Business Terpene Synthetic Resin 94% Terpene Operations 6% Synthetic Resin Operations Note: The retail percentage is NIL in the s
6%
ngalam Organics Limited Business-to-Business Terpene Synthetic Resin 94% Terpene Operations 6% Synthetic Resin Operations Note: The retail percentage is NIL in the standalone revenue because
7.39%
Retail Operations 12 Financials FY25 Consolidated Financial Performance Revenues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 F
51.49 %
Consolidated Financial Performance Revenues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Mar
196.91%
enues (Rs. Crs) +7.39% 530.01 493.52 EBITDA (Rs. Crs) + 51.49 % 58.58 38.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25
321
bps
8.67 PAT (Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps 2.36% FY25 0.85% FY24 • Revenue growth o
11.05%
(Rs. Crs) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps 2.36% FY25 0.85% FY24 • Revenue growth of 7.39 %
7.84%
s) +196.91% 12.50 4.21 FY25 FY24 FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps 2.36% FY25 0.85% FY24 • Revenue growth of 7.39 % in FY2
151 bps
FY25 FY24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps 2.36% FY25 0.85% FY24 • Revenue growth of 7.39 % in FY25 vs FY24. • Decrease in input cost
2.36%
Y24 FY25 FY24 EBITDA Margin (%) +321 bps 11.05% 7.84% FY25 FY24 PAT Margin (%) + 151 bps 2.36% FY25 0.85% FY24 • Revenue growth of 7.39 % in FY25 vs FY24. • Decrease in input costs lead
Advertisement